CoChat

Efficacy of methotrexate in Crohn’s disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine

Open access
WAHED, M., LOUIS‐AUGUSTE, J. R., BAXTER, L. M., LIMDI, J. K., MCCARTNEY, S. A., LINDSAY, J. O., BLOOM, S. L. · 2009 · Alimentary Pharmacology & Therapeutics
Cited by 98

The DOI matches its Crossref record.

Abstract

Summary: Background Despite the wide use of azathioprine/mercaptopurine (AZA/MP) therapy in the management of both Crohn’s disease (CD) and ulcerative colitis (UC), approximately 20% of patients cannot tolerate the drugs and 30% do not respond. Aim To examine the efficacy and safety profile of methotrexate (MTX) in patients with CD or UC who are either intolerant or non‐responsive to AZA/MP. Methods A total of 131 patients with IBD treated with MTX were identified. Retrospective data were obtained by case note review. Clinical response (defined as steroid withdrawal, normalization of previously raised CRP or physician’s clinical assessment of improvement) was assessed at 6 months. Results Clinical response in Crohn’s disease occurred in 18 of 29 patients (62%) refractory to AZA/MP and 42 of 70 patients (60%) intolerant to AZA/MP, with no difference between the groups (P = 1.0). In UC, clinical response was seen in 7 of 9 (78%) patients refractory to AZA/MP and 15 of 23 (65%) intolerant to thiopurines. MTX was well tolerated in a majority of individuals. Conclusions Methotrexate appears effective in both CD and UC patients who fail to respond to or are intolerant to AZA/MP therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1365-2036.2009.04073.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 98

Metadata

Authors
WAHED, M., LOUIS‐AUGUSTE, J. R., BAXTER, L. M., LIMDI, J. K., MCCARTNEY, S. A., LINDSAY, J. O., & BLOOM, S. L.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2009-08-18
Volume
30
Issue
6
Pages
614-620
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W1992761307
Cited by
98
References
0
FWCI
4.99
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy of methotrexate in Crohn’s disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine. https://app.cochat.ai/papers/10.1111/j.1365-2036.2009.04073.x
The paper
WAHED, M., LOUIS‐AUGUSTE, J. R., BAXTER, L. M., LIMDI, J. K., MCCARTNEY, S. A., LINDSAY, J. O., & BLOOM, S. L. (2009). Efficacy of methotrexate in Crohn’s disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/j.1365-2036.2009.04073.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.